about
Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγEndothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of AdiponectinArterial stiffness and cardiovascular therapyPeroxisome proliferator-activated receptors for hypertension.Altered mitochondrial apoptotic pathway in placentas from undernourished rat gestations.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.Regulation of lipid metabolism-related gene expression in whole blood cells of normo- and dyslipidemic men after fish oil supplementation.Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.Association between left ventricular hypertrophy and changes in arterial stiffness during hypertensive treatment.KLF2-mediated Disruption of PPARγ Signaling in Lymphatic Endothelial Cells Exposed to Chronically Increased Pulmonary Lymph Flow.Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.The Nuclear Receptor Field: A Historical Overview and Future ChallengesChronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defectsC/VDdb: A multi-omics expression profiling database for a knowledge-driven approach in cardiovascular disease (CVD)
P2860
Q28541836-5588D705-C3E3-4D5B-854B-BDA654A20F9EQ33675999-4CD5C585-67A0-4899-A285-1F138D25B1C6Q34079790-B98B4372-DBEA-40FC-80DE-81D4CDADF264Q34179017-1EE91C02-6E8F-41F0-8A3F-FF270E7D8434Q35601550-8AE5DF05-1F94-4A7D-A7D1-E67D7BD756B2Q36261125-46D75B4B-78C0-42DE-94A5-39F567426A1EQ36368271-8F8C7BA8-D074-4F8D-904B-9DE7042B418AQ36527069-EBC0A223-2A42-4933-81B8-9E897E9BAACFQ37363651-DCA7C835-C48E-4983-8F8C-1F96C6B9AB0BQ38641190-D05786C4-77D9-4107-A61E-F67BCA15EC62Q39018398-72899B75-D4AF-4C7A-9F0F-9914D403B7A4Q45799869-E9093E29-0994-4E54-85D2-CE23828B7405Q52690912-B9E75D18-9C0B-4718-BC26-E271827F204EQ55088439-562D5CF4-1676-40A9-A831-83268CE30DF5Q57179384-9E177C75-49F4-4086-92F6-62751D81A62FQ58816207-CCDEDF91-6D11-42EF-97FA-6B656F03DB75Q59136824-642DEBBC-B2D5-4ED3-B70B-567BF01EF0A9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPARs and their effects on the cardiovascular system.
@en
PPARs and their effects on the cardiovascular system.
@nl
type
label
PPARs and their effects on the cardiovascular system.
@en
PPARs and their effects on the cardiovascular system.
@nl
prefLabel
PPARs and their effects on the cardiovascular system.
@en
PPARs and their effects on the cardiovascular system.
@nl
P2860
P1476
PPARs and their effects on the cardiovascular system.
@en
P2093
Adebayo Oyekan
P2860
P304
P356
10.3109/10641963.2010.531845
P577
2011-07-01T00:00:00Z